MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/19433654251376289

Медицинская библиотека · Respiratory care · 2026

PaO2/FIO2-Based Stratification Discriminates Treatment Failure in Nonintubated Subjects With ARDS.

Sakuraya Masaaki, Nagata Kazuma, Yokoyama Toshiki, Tsugitomi Ryosuke, Nakashima Harunori, Kuraishi Hiroshi, Ohshimo Shinichiro, Mori Yoshihiro, Kagami Ryogo, Tobino Kazunori, Kamo Tetsuro, Kadowaki Toru, Koga Yasutaka, Ogata Yoshitaka, Nishimura Naoki, Kondoh Yasuhiro, Tomii Keisuke, JaNP-Hi Study Investigators

СтатьяМногоцентровое исследованиеРандомизированное исследованиеПеревод в очереди

Аннотация

BACKGROUND

The new global definition of nonintubated subjects with ARDS can be applied to patients receiving high-flow nasal cannula (HFNC), but stratification with PaO2/FIO2 has not been validated. We aimed to investigate the differences in oxygenation assessment between HFNC and CPAP for predicting outcomes.

METHODS

We performed a post hoc analysis of a multi-center randomized controlled trial conducted in Japan, focusing on oxygenation assessments in subjects receiving HFNC or CPAP. Subjects with PaO2/FIO2 < 300 on CPAP at 5 cm H2O were assigned to receive either HFNC or CPAP. Subjects were stratified into mild (PaO2/FIO2 ≥ 200 but <300), moderate (PaO2/FIO2 ≥ 100 but < 200), or severe (PaO2/FIO2 < 100) hypoxemia categories based on oxygenation levels during CPAP at 5 cm H2O. The primary outcome was treatment failure (intubation or in-hospital death). Discriminative performance for treatment failure was evaluated using the area under the receiver operating characteristic curve (AUROC) for each device.

RESULTS

Of the 85 subjects analyzed, 31, 48, and 6 were classified as having mild, moderate, and severe hypoxemia, respectively. Treatment failure occurred more frequently in subjects with moderate and severe hypoxemia than in those with mild hypoxemia (mild 1/31 [3.2%], moderate: 12/48 [25.0%], severe: 3/6 [50.0%], P = .004). Compared with 1 of 38 subjects (2.6%) treated with CPAP, 21 of 47 subjects (44.7%) with HFNC experienced worsened oxygenation even after 30 min of treatment (P < .001). Subjects with HFNC had a lower AUROC of PaO2/FIO2 for treatment failure (0.66, 95% CI 0.54-0.79) than those with CPAP (0.82, 95% CI 0.74-0.90, P = .041).

CONCLUSIONS

PaO2/FIO2-based stratification may help predict treatment failure in patients with nonintubated subjects with ARDS. However, a thorough oxygenation assessment is necessary because of the variability introduced by different respiratory support devices. CPAP might be superior to HFNC when predicting treatment failure.

Для цитирования: Sakuraya Masaaki, Nagata Kazuma, Yokoyama Toshiki, Tsugitomi Ryosuke, Nakashima Harunori, Kuraishi Hiroshi, Ohshimo Shinichiro, Mori Yoshihiro, Kagami Ryogo, Tobino Kazunori, Kamo Tetsuro, Kadowaki Toru, Koga Yasutaka, Ogata Yoshitaka, Nishimura Naoki, Kondoh Yasuhiro, Tomii Keisuke, JaNP-Hi Study Investigators. PaO2/FIO2-Based Stratification Discriminates Treatment Failure in Nonintubated Subjects With ARDS.. Respiratory care. 2026. DOI: 10.1177/19433654251376289.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.